Enveric Biosciences Inc. (ENVB)
NASDAQ: ENVB
· Real-Time Price · USD
1.08
-0.03 (-2.70%)
At close: Aug 15, 2025, 3:57 PM
1.09
0.98%
After-hours: Aug 15, 2025, 07:16 PM EDT
Enveric Biosciences Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 4.29M | 2.24M | 3.11M | 3.5M | 6.36M | 2.29M | 4.27M | 7.08M | 12.56M | 17.72M | 21.2M | 18.01M | 21.69M | 17.36M | 21.45M | 20.62M | 22.66M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 1.82M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | 567.6K | 0.00 | -0.00 | 0.00 | -0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | n/a | n/a | 17.76K | 299.32K | n/a | 224.61K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | -17.76K | n/a | -455.78K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | 772.33K | 763.17K | 1.09M | 567.6K | 1.56M | 1.82M | 2.28M | n/a | 1.07M | 1.36M | n/a | 380.84K | 833.12K | 891.47K | 767.3K |
Total Current Assets | 4.83M | 2.73M | 4.34M | 5.52M | 8.23M | 3.01M | 5.83M | 8.9M | 14.84M | 18.43M | 22.27M | 19.37M | 22.67M | 17.74M | 22.28M | 21.51M | 23.42M |
Property-Plant & Equipment | 267.28K | 305.78K | 367.69K | 405.11K | 452.23K | 507.38K | 539.15K | 604.84K | 675.98K | 741.3K | 801.71K | 904.42K | 928.11K | 470.73K | 140.57K | n/a | n/a |
Goodwill & Intangibles | n/a | 42.18K | 84.37K | 126.56K | 168.74K | 210.93K | 253.12K | 295.31K | 337.5K | 379.69K | 7.79M | 8.3M | 8.59M | 8.51M | 47.34M | 2.19M | 2.36M |
Total Long-Term Assets | 267.28K | 347.96K | 452.06K | 531.67K | 620.97K | 3.1M | 792.27K | 900.15K | 1.01M | 1.12M | 8.59M | 9.2M | 9.51M | 8.98M | 47.48M | 2.19M | 2.36M |
Total Assets | 5.1M | 3.08M | 4.79M | 6.05M | 8.85M | 6.12M | 6.62M | 9.8M | 15.85M | 19.55M | 30.86M | 28.57M | 32.18M | 26.72M | 69.76M | 23.69M | 25.79M |
Account Payables | 669.19K | 521.75K | 576.32K | 459.9K | 1.85M | 1.22M | 1.1M | 1.23M | 1.79M | 463.27K | 710.31K | 754.3K | 1.22M | 683.39K | 2.16M | 1.02M | 626.95K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.02M | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.61K | 37.04K | n/a | 88.77K | 111.1K | n/a | n/a | n/a | 148.6K | n/a |
Other Current Liabilities | n/a | 3.09K | 9.69K | 176.81K | 141.17K | 328.4K | 2.15M | 2.89M | 1.76M | 1.76M | 597.23K | 343.9K | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 1.18M | 1.49M | 839.17K | 645.34K | 2.37M | 2.34M | 4.18M | 4.93M | 4.44M | 4M | 2.6M | 2.32M | 2.09M | 2.08M | 2.16M | 1.17M | 626.95K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.17M | 2M | 3.97M | 653.67K | 3.17M | 3.71M | 6.17M |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.41M | 527.1K | 4.66M | 3.64M | 5.64M | 2.33M | 12.23M | 3.71M | 6.17M |
Total Liabilities | 1.18M | 1.49M | 839.17K | 645.34K | 2.37M | 2.34M | 4.18M | 4.93M | 4.44M | 4M | 7.25M | 5.97M | 7.74M | 4.41M | 14.39M | 4.88M | 6.79M |
Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.61K | 37.04K | 63.82K | 88.77K | 120.97K | 151.32K | 176.3K | n/a | 148.6K | n/a |
Common Stock | 24.72K | 6.78K | 89.95K | 78.78K | 72.94K | 27.39K | 21.82K | 21.42K | 20.78K | 20.78K | 20.78K | 10.54K | 526.23K | 325.79K | 313.84K | 214.33K | 194.5K |
Retained Earnings | -108.26M | -106.07M | -102.92M | -100.84M | -98.96M | -96.5M | -93.06M | -90.24M | -83.89M | -79.21M | -70.53M | -68.05M | -65.26M | -60.74M | -18.63M | -15.92M | -15.01M |
Comprehensive Income | -598K | -594.52K | -535K | -566.5K | -551.84K | -569.75K | -535.62K | -546.05K | -534.77K | -536.73K | -640.5K | -223.11K | 57.91K | -30.8K | -185.31K | -178.8K | -145.54K |
Shareholders Equity | 3.92M | 1.59M | 3.95M | 5.41M | 6.48M | 3.77M | 2.44M | 4.87M | 10.41M | 14.67M | 22.84M | 21.97M | 24.44M | 22.31M | 55.37M | 18.82M | 18.99M |
Total Investments | n/a | n/a | n/a | n/a | n/a | 1.82M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |